Tegoyes 15mg Capsule 7’s

Product Details

Tegoyes 15mg Capsule combines the active ingredients Tegafur, Gimeracil, and Oteracil. This combination is primarily used in the treatment of advanced gastric cancer. Tegafur is a chemotherapy agent that converts into 5-fluorouracil (5-FU) in the body, which then inhibits DNA synthesis in cancer cells. Gimeracil enhances the effectiveness of Tegafur by inhibiting the enzyme that breaks down 5-FU, while Oteracil reduces gastrointestinal toxicity by limiting 5-FU activation in the gut. Together, these ingredients provide an effective and well-tolerated treatment for gastric cancer.

Uses:

• Treatment of advanced gastric cancer, typically in combination with other chemotherapy agents.

Side Effects:

• Common side effects: nausea, vomiting, diarrhea, loss of appetite, and fatigue.
• Serious side effects: myelosuppression (reduced blood cell production), liver toxicity, and risk of severe infections. Immediate medical attention is required for symptoms like high fever, severe weakness, or unusual bleeding.

Key Features:

• Contains Tegafur, Gimeracil, and Oteracil, a combination therapy targeting gastric cancer cells.
• Reduces DNA synthesis in cancer cells to slow or stop tumor growth.
• Gimeracil enhances the efficacy of chemotherapy, while Oteracil minimizes side effects.
• Provides a targeted approach for managing advanced gastric cancer.

FAQ:

1. How does Tegoyes 15mg Capsule work in cancer treatment?
   Tegoyes contains Tegafur, which converts to 5-FU to disrupt cancer cell DNA, while Gimeracil and Oteracil optimize the treatment by enhancing efficacy and minimizing gastrointestinal side effects.
2. Who can use Tegoyes?
   Tegoyes is prescribed for adults with advanced gastric cancer, often as part of a combined chemotherapy regimen. Your oncologist will determine if it’s suitable for your condition.
3. What precautions should I take while on Tegoyes?
   Regular blood tests are necessary to monitor blood counts and liver function. Avoid contact with infections, and report any unusual symptoms like persistent weakness, fever, or bleeding to your doctor.

References:

1. Taiho Pharmaceutical Co., Ltd. “Tegafur, Gimeracil, and Oteracil combination capsules.” [Accessed on 5 Nov 2024]. Available from: https://pubmed.ncbi.nlm.nih.gov/22162925/
2. European Medicines Agency (EMA). “Combination of Tegafur, Gimeracil, and Oteracil Product Information.” [Accessed on 5 Nov 2024]. Available from: https://en.wikipedia.org/wiki/Tegafur/gimeracil/oteracil